Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: Results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation-Reference-Cited by-同舟云学术

Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: Results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation

Published:1997-03 Issue:4 Volume:37 Page:797-802
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Reddy Sarada P.,Marks James E.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference12 articles.

1. Cervical nodal metastases of unknown origin;Barrie;Am. J. Surg.,1970

2. Guidelines for radiotherapeutic techniques for cervical metastases from an unknown primary;Carlson;Int. J. Radiat. Oncol. Biol. Phys.,1986

3. Metastases to lymph nodes of the head and neck from an unknown primary site;Coker;Am. J. Surg.,1977

4. Metastatic carcinoma in the cervical lymph nodes from an occult primary: A conservative approach to the role of radiotherapy;Gilynne-Jones;Int. J. Radiat. Oncol. Biol. Phys.,1990

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is bilateral radiotherapy necessary for patients with unilateral squamous cell carcinoma of unknown primary of the head and neck region?;Clinical and Translational Radiation Oncology;2024-03

2. Management of unknown primary head and neck cancer with radiation therapy in the era of human papillomavirus (HPV): No longer cutting down the tree to get an apple;Radiotherapy and Oncology;2023-12

3. Cancer of unknown primary (CUP) – lokal begrenzt, oligometastatisch und im Kopf-Hals-Bereich;Die Radiologie;2023-03-21

4. Solid Swellings of the Anterior Triangle: Cervical Lymphadenopathy;Lateral Neck Swellings;2023

5. Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary;Radiotherapy and Oncology;2022-10